SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, Daria Lemann-Blumenthal, LLB, EMBA, CEO of Belkin Laser, discusses the company’s clinical-stage automated 1-second laser treatment.
“Our vision is to promote accessibility to glaucoma care by offering a very simple, intuitive procedure that can be applied by any ophthalmologist as the first-line treatment of choice anywhere in the world,” she said.
Uncategorized